// App-Quantinova.ai

: Novel Drugs to Target JAK2 Rearrangements in Pediatric Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Manuel Quadri

Principal Investigators

  • Claudia Saitta

  • Sonia Palamini

  • Chiara Palmi

  • Jia-Wey Tu

  • Sanil Bhatia

  • Arndt Borkhardt

  • Andrea Biondi

  • Giovanni Cazzaniga

  • Grazia Fazio

Medical Centers

  • Tettamanti Research Center, Dept. Pediatrics, Clinica Pediatrica Univ. Milano Bicocca Ospedale San Gerardo, Monza, Italy

  • Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany

  • Tettamanti Research Center, Pediatrics, Department of Medicine, University of Milano-Bicocca, Monza, Italy

  • Medical Genetics, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy

  • Tettamanti Research Center, Pediatrics, University of Milano-Bicocca / Fondazione Tettamanti, Monza, Italy

  • Tettamanti Research Center, Dept. Pediatrics, University of Milano-Bicocca, Fondazione MBBM/San Gerardo Hospital, Monza, Italy

Locations

  • Italy

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved